Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma

Journal of Clinical Virology

Volumn 40, Issue 4, 2007, Pages 284-288

  Tang, Julian W ^a   Rohwäder, Edda ^b   Chu, Ida M T ^a   Tsang, Raymond K Y ^a   Steinhagen, Katja ^b   Yeung, Apple C M ^a   To, K F ^c   Chan, Paul K S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Institute of Experimental Immunology   (Germany)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; Early antigen; Epstein Barr virus; Nasopharyngeal carcinoma; Virus capsid antigen

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOFLUORESCENCE; MALE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CAPSID PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 36348982127     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.09.006     Document Type: Article

References (13)

1. Chan K.H., Gu Y.L., Ng F., Ng P.S., Seto W.H., Sham J.S., et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer 105 (2003) 706-709
2. Chan S.H., Soo M.Y., Gan Y.Y., Fones-Tan A., Sim P.S., Kaur A., et al. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC-comparison between IFA and two commercial ELISA kits. Singapore Med J 39 (1998) 263-265
3. Fachiroh J., Schouten T., Hariwiyanto B., Paramita D.K., Harijadi A., Haryana S.M., et al. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Infect Dis 190 (2004) 53-62
4. Fan H., Nicholls J., Chua D., Chan K.H., Sham J., Lee S., et al. Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus. Int J Cancer 112 (2004) 1036-1041
5. Karray H., Ayadi W., Fki L., Hammami A., Daoud J., Drira M.M., et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol 75 (2005) 593-602
6. Ng W.T., Yau T.K., Yung R.W., Sze W.M., Tsang A.H., Law A.L., et al. Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer 113 (2005) 998-1001
7. Puthavathana P., Kositanont U., Chongkolwatana C., Metheetrairut C., Chantarakul N., Nuntarakchaikul S., et al. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma. Asian Pac J Allergy Immunol 11 (1993) 39-43
8. Puthavathana P., Sutthent R., Vitavasiri A., Wasi C., Chantarakul N., and Thongcharoen P. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand. Southeast Asian J Trop Med Public Health 22 (1991) 326-331
9. Shao J.Y., Zhang Y., Li Y.H., Gao H.Y., Feng H.X., Wu Q.L., et al. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Anticancer Res 24 (2004) 4059-4066
10. Stevens S.J., Verkuijlen S.A., Hariwiyanto B., Harijadi Fachiroh J., Paramita D.K., Tan I.B., et al. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 43 (2005) 3066-3073
11. Tsang R.K., Vlantis A.C., Ho R.W., Tam J.S., To K.F., and van Hasselt C.A. Sensitivity and specificity of Epstein-Barr virus IgA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. Head Neck 26 (2004) 598-602
12. Wei W.I., and Sham J.S. Nasopharyngeal carcinoma. Lancet 365 (2005) 2041-2054
13. Yang X.R., Diehl S., Pfeiffer R., Chen C.J., Hsu W.L., Dosemeci M., et al., Chinese and American Genetic Epidemiology of NPC Study Team. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 14 (2005) 900-905